Jefferies Group LLC Lannett CO Inc Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$5.35 - $9.82 $159,574 - $292,901	-29,827 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $149,369 - $269,562	-43,548 Reduced 59.35%	29,827 $148,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $68,518 - $209,162	-14,425 Reduced 16.43%	73,375 $349,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $1.17 Million - $1.53 Million	87,800 New	87,800 $1.19 Million
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $496,860 - $843,310	-33,800 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $175,120 - $257,400	8,800 Added 35.2%	33,800 $784,000
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $377,500 - $481,250	25,000	25,000 $461,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.